# Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

> **NCT00104676** · PHASE3 · COMPLETED · sponsor: **UNICANCER** · enrollment: 263 (actual)

## Conditions studied

- Extragonadal Germ Cell Tumor
- Teratoma
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** cisplatin
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** oxaliplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00104676
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11-26
- **Primary completion:** 2012-03-29
- **Final completion:** 2023-02-08
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104676, "Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00104676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*